Soyez toujours en bonne forme et soyez réussi, comme Oleg Taktarov!La brillante étoile de la constellation InstaSpot!

L'acteur, le champion de l'UFC et un vrai bogatyr russe! . Homme qui ne doit sa réussite qu'à lui-même. L'homme qui est sur la même route que nous suivons. Le secret du succès de Taktarov est le progrès permanent vers la réalisation de son objectif.
Découvrez toutes les facettes de votre talent! Apprenez, essayez, commettez des erreurs, mais ne vous arrêtez pas!

InstaSpot - L'histoire de votre succès commence ici !

For Traders

Charts

#BGNE

#BGNE (BeiGene Ltd.). Taux de change et graphiques en ligne.

#AZN Return to the list of instruments #BIIB

Currency converter

189.09 USD
26 Nov 2024 20:31

$-0.2
(-0.11%)

Prev Close

$189.02

Open

$191.2

Day's High

$190.36

Day's Low

$185.22

Week High

$190.36

Week Low

$183.79

Download archive

Open the chart in full screen view

Download archive

Open the chart in full screen view

BeiGene Ltd. About company

BeiGene Ltd. is a China-based biotechnology company founded in 2010 in Beijing. Nowadays, the company operates on an international scale with its branches established in the US, Australia, and Europe.

The company focuses on the development of drugs for cancer treatment. Since 2019, BeiGene Ltd. has been in partnership with Amgen Inc. and since, 2021 – with Novartis.

The market capitalization of BeiGene Ltd. is worth $17.7 billion. The company yielded a profit of $1.176 billion last year. In the first half of 2022, it earned $341.57 million. On the flip side, its net losses measured $1.413 billion in 2021 and $571.45 million in the first half of 2022.

BeiGene Ltd.’s stock and what influences its market quotes

BeiGene Ltd.’s stock has traded on the Nasdaq exchange under a BGNE ticker since 2016. Shortly after the listing, the shares traded at $24 apiece.

For the time being, the stock is trading in the range of $138 to $145. The stock has traded between the borders of $121.11 and $389.34 over the last 12 months.

The company does not pay dividends. All funds raised through investments are allocated for research and development.

What factors should investors keep an eye on when trading this asset:

BeiGene’s business belongs to a rapidly-developing sector. So, the company should have its finger on the pulse of science not to lag behind its competitors.
The major risk is that the company is sensitive to regulatory acts.
Washington slaps sanctions on Chinese companies now and then. In this context, they might be delisted from American exchanges.
The company ranks high. Hence, its stock is attractive to investors.

InstaSpot – choix de millions!Et cela a plus de poids que toute parole!

Soyez toujours en bonne forme et soyez réussi, comme Oleg Taktarov!La brillante étoile de la constellation InstaSpot!

#BGNE (BeiGene Ltd.). Taux de change et graphiques en ligne.

Currency converter

BeiGene Ltd. About company

BeiGene Ltd.’s stock and what influences its market quotes